Hydreight Technologies Inc. (NURS) Earnings Call Transcripts

Hydreight Technologies Inc.'s Latest Earnings Call - Q4 FY2025

In Q4 2025, Hydreight Technologies Inc. reported total revenue of $14.9 million, reflecting a significant 270% year-over-year growth, with full-year revenue reaching $35.4 million, up 121% from the previous year. The company achieved an adjusted EBITDA margin of 11% in Q4, a substantial increase from 3.4% earlier in the year. Management reaffirmed guidance for fiscal 2026, projecting a minimum of $150 million in revenue, driven by the ramp-up of existing licensees and continued onboarding of new partners, indicating strong operational momentum heading into 2026.

Reported metrics

Guidance from management

Management reaffirmed revenue guidance for fiscal 2026 at a minimum of $150 million, citing strong confidence in the ramp-up of existing partners and increased prescription volumes.

What management said

Thank you so much, Shane. Thank you, everyone, for joining today's call. A replay will be available to everybody on hydrates website in the Investor Relations section of hydreight.com and we will also be sending an e-mail to everyone with the recording as well. So thank you very much for joining us today, and we wish you guys a great rest of your day and weekend as well. Thank you so much. Bye now.

What analysts pressed on

Analysts expressed concerns regarding the sustainability of revenue growth and the potential impact of lower gross margins due to the shift towards pharmacy sales. There were also questions about the scalability of the business model as it expands into new product categories.

Main topics on the call

• Revenue Growth — Hydreight reported a Q4 revenue of $14.9 million, up from $4 million in Q4 2024, marking a 270% year-over-year increase. For the full year, revenue was $35.4 million, a 121% growth compared to $16 million in 2024, driven...
• Operating Leverage — The company demonstrated significant operating leverage, with revenue growth of 157% in the second half of 2025 while operating expenses increased by only 18%. This resulted in an adjusted EBITDA margin that tripled from...
• Balance Sheet Improvement — Hydreight transformed its balance sheet, ending 2025 with $16 million in cash and a working capital surplus of $16 million, compared to just over $1 million in cash at the beginning of the year. This improvement was bols...
• Future Guidance — Management reaffirmed guidance for fiscal 2026, projecting a minimum of $150 million in revenue. This guidance is based on the ramp-up of existing partners and increased prescription volumes, indicating strong confidence...

Read the full Hydreight Technologies Inc. transcript (Q4 FY2025) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 7 Hydreight Technologies Inc. earnings call transcripts on record, spanning January 22, 2025 to June 2, 2026. Based on this history, Hydreight Technologies Inc. reports quarterly. The most recent call on file is dated June 2, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

NURS

Exchange

TSXV

Country

CA

Sector

Health Care

Industry

Health Care Technology

Calls on record

7

First call

January 22, 2025

Most recent

June 2, 2026

Reporting cadence

quarterly